LRRK2 and Parkinson disease: Aberrant JIP4-TMEM55B-dependent control of lysosomal cystine efflux may thus contribute to the effects of LRRK2 gain-of-function mutations that give rise to Parkinson’s disease (Alessi & Pfeffer, 2024).